BRPI0512756A - composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas - Google Patents

composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas

Info

Publication number
BRPI0512756A
BRPI0512756A BRPI0512756-4A BRPI0512756A BRPI0512756A BR PI0512756 A BRPI0512756 A BR PI0512756A BR PI0512756 A BRPI0512756 A BR PI0512756A BR PI0512756 A BRPI0512756 A BR PI0512756A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
pain
capsules
control method
including tablets
Prior art date
Application number
BRPI0512756-4A
Other languages
English (en)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of BRPI0512756A publication Critical patent/BRPI0512756A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

COMPOSIçãO FARMACêUTICA DE COMBINAçãO PARA O TRATAMENTO DE DOR, MéTODO DE CONTROLE DE DOR, USO DE UMA COMPOSIçãO E EMBALAGEM FARMACêUTICA INCLUINDO COMPRIMIDOS OU CáPSULAS Composição farmacêutica de combinação para o tratamento de dor, a qual inclui de aproximadamente 125 mg a aproximadamente 150 mg de ibuprofen e de aproximadamente 475 mg a aproximadamente 500 mg de paracetamol.
BRPI0512756-4A 2004-07-07 2005-07-07 composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas BRPI0512756A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
PCT/NZ2005/000168 WO2006004449A2 (en) 2004-07-07 2005-07-07 A combination composition

Publications (1)

Publication Number Publication Date
BRPI0512756A true BRPI0512756A (pt) 2008-04-08

Family

ID=35783254

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512756-4A BRPI0512756A (pt) 2004-07-07 2005-07-07 composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas

Country Status (20)

Country Link
US (4) US20080275125A1 (pt)
EP (1) EP1781277B1 (pt)
JP (1) JP5630943B2 (pt)
KR (1) KR101370712B1 (pt)
CN (1) CN101022789A (pt)
AT (1) ATE543491T1 (pt)
AU (2) AU2005260243B2 (pt)
BR (1) BRPI0512756A (pt)
CA (1) CA2570474C (pt)
CY (1) CY1112738T1 (pt)
DK (1) DK1781277T3 (pt)
ES (1) ES2381794T3 (pt)
GB (1) GB2431346C (pt)
MX (1) MX2007000117A (pt)
PL (1) PL1781277T3 (pt)
PT (1) PT1781277E (pt)
RU (2) RU2007101686A (pt)
SI (1) SI1781277T1 (pt)
WO (1) WO2006004449A2 (pt)
ZA (1) ZA200700896B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570474C (en) 2004-07-07 2010-01-05 Aft Pharmaceuticals Limited A combination composition comprising paracetamol and ibuprofen
WO2007069033A2 (en) * 2005-12-12 2007-06-21 Adcock Ingram Limited Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
ES2651444T3 (es) * 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
CA2731801C (en) * 2007-07-23 2013-11-26 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
KR20110065417A (ko) * 2008-01-03 2011-06-15 욱크하르트 리미티드 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액
NZ591496A (en) * 2008-10-14 2012-12-21 Aft Pharmaceuticals Ltd A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
AU2011274652B2 (en) * 2010-07-07 2013-08-15 Aft Pharmaceuticals Limited A combination composition comprising ibuprofen and paracetamol
US20130225685A1 (en) 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
BR112013028668A2 (pt) * 2011-05-06 2017-01-24 Glaxosmithkline Llc formulações de paracetamol de liberação sustentada
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
KR102642847B1 (ko) * 2017-07-10 2024-03-04 젤 캡 테크놀로지스 엘엘씨 이중 방출 투여형 캡슐 및 이를 제조하기 위한 방법, 장치 및 시스템
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
EP3989944A1 (en) 2019-06-27 2022-05-04 PF Consumer Healthcare 1 LLC Novel ibuprofen and acetaminophen composition
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
CA2570474C (en) 2004-07-07 2010-01-05 Aft Pharmaceuticals Limited A combination composition comprising paracetamol and ibuprofen
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
NZ591496A (en) 2008-10-14 2012-12-21 Aft Pharmaceuticals Ltd A medicinal comprising ibuprofen and paracetamol and treatment for arthritis

Also Published As

Publication number Publication date
GB2431346A (en) 2007-04-25
EP1781277B1 (en) 2012-02-01
WO2006004449A2 (en) 2006-01-12
MX2007000117A (es) 2007-06-15
DK1781277T3 (da) 2012-05-07
SI1781277T1 (sl) 2012-07-31
GB2431346B (en) 2010-01-27
RU2455983C1 (ru) 2012-07-20
US20110275718A1 (en) 2011-11-10
CA2570474C (en) 2010-01-05
CA2570474A1 (en) 2006-01-12
RU2007101686A (ru) 2008-08-20
EP1781277A2 (en) 2007-05-09
ZA200700896B (en) 2008-07-30
US10532036B2 (en) 2020-01-14
ES2381794T3 (es) 2012-05-31
RU2010147287A (ru) 2012-05-27
CN101022789A (zh) 2007-08-22
JP5630943B2 (ja) 2014-11-26
AU2005260243B2 (en) 2009-10-29
CY1112738T1 (el) 2016-02-10
KR20070034614A (ko) 2007-03-28
US20080275125A1 (en) 2008-11-06
ATE543491T1 (de) 2012-02-15
AU2008202029A1 (en) 2009-11-26
EP1781277A4 (en) 2008-09-03
US20080200549A1 (en) 2008-08-21
PT1781277E (pt) 2012-05-07
JP2008505889A (ja) 2008-02-28
PL1781277T3 (pl) 2012-07-31
GB0700027D0 (en) 2007-02-07
KR101370712B1 (ko) 2014-03-06
US20140073696A1 (en) 2014-03-13
AU2005260243A1 (en) 2006-01-12
WO2006004449A3 (en) 2006-03-02
GB2431346C (en) 2010-02-17

Similar Documents

Publication Publication Date Title
BRPI0512756A (pt) composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1118179T1 (el) Φαρμακευτικη συνθεση
BRPI0418228A (pt) forma de dosagem, e, métodos de tratamento de dor e de episódios de dor incidente de cáncer, e de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
SE0203817D0 (sv) New composition
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
MY154883A (en) A combination composition
DE50304524D1 (de) Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole
MXPA01011964A (es) Forma de unidad de dosis farmaceutica del tipo de capsulas rigidas que contiene clonixinato de lisina, procedimiento para su preparacion y el uso de dicha unidad de dosis como analgesico y7o antiinflamatorio.

Legal Events

Date Code Title Description
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA PETICAO NO 018110026680 DE 13/07/2011 EM VIRTUDE DOS DISPOSTO NO ARTIGO 219, INCISO II,DA LPI.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B15W Others matters related to applications: legal action concerning application

Free format text: INPI NO 52402.012101/2022-18 ORIGEM: 9A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5080684-80.2022.4.02.5101/RJ NULIDADE DE ATO ADMINISTRATIVO AUTOR: AFT PHARMACEUTICALS LIMITED REU(S): INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL